Skip to content
Quant500 - Quantitative Analysis
Search ticker or company...
ES | EN

Company Profile: Kenvue Inc. (KVUE)

KVUE insider trades (13 months) →

$19.31 −1.28% vs. previous close · Market cap $37.11B

Quant500 Scores
Momentum
-
Value
-
Growth
-
Quality
-
Multifactor
-

Market and Valuation

Price & Market

Prev Close Price:$19.56
Open:$19.99
Day's Low:$19.20
Day's High:$20.00
Bid / Ask:-
Market Cap:37.11B
Enterprise Value:44.41B

52-Week Range

52-Week Low:$15.88
52-Week High:$20.13
Current position in 52-week range
52w Low-52w High
50-Day Avg:$18.40
200-Day Avg:$18.22

Volume

Volume Today:66,377,525
Avg Volume (3m):22,508,816
Avg Volume (10d):20,096,007
52-Week Change:+20.91%
vs S&P 500, 52 weeks:-
Beta:0.40

Valuation Multiples

P/E (trailing):21.94

Diluted EPS for the last 12 months: the four quarters ended Sep 27, 2026, from the accounts filed with the SEC on Oct 30, 2026. The P/E is the price divided by that EPS.

P/E (forward):15.58
PEG Ratio:1.53
Price / Book:3.65
Price / Sales (TTM):2.39
EV / Revenue:2.86
EV / EBITDA:12.67

Dividends

Current yield:4.35%
Annual Dividend Rate:$0.84
Dividend Trailing:$0.83
Yield Trailing:4.26%
5-Year Avg Yield:-
Payout Ratio:94.60%
Last Ex-Dividend Date:-

Valuation Context

P/E vs sector (indicative)

Most Recent Quarter:-
Fiscal Year (Next):-

Loading historical OHLCV database...

Financial Statements TTM (Trailing 12 Months)

Income Statement

Total Revenue (TTM):15.53B
Gross Profit:9.09B
EBITDA:3.50B
Net Income (TTM):1.69B
Rev Growth (YoY):+3.20%
Earnings Growth (YoY):+6.00%
Quarterly earnings growth (YoY):+8.00%

Margins

Gross Margin:-
EBITDA Margin:-
Operating Margin:-
Net Margin:-

Per Share

EPS Trailing (TTM):$0.88

Diluted EPS for the last 12 months: the four quarters ended Sep 27, 2026, from the accounts filed with the SEC on Oct 30, 2026. The P/E is the price divided by that EPS.

EPS Forward (Est.):$1.24
Revenue Per Share:$8.10
Cash Per Share:-
Book Value:$5.29
Last Dividend:-
Ex-Dividend Date:-
Last Split:-

Balance Sheet & Liquidity

Total cash:1.04B
Total Debt:8.34B
Net Debt (Debt - Cash):7.30B
Debt / Equity:82.08%
Current Ratio:0.96
Quick Ratio:0.57

Cash Flows

Operating Cash Flow:2.73B
Free Cash Flow (FCF):2.77B
FCF Yield (FCF / Market Cap):-
Enterprise Value:44.41B
EV / Revenue:2.86
EV / EBITDA:12.67

Profitability

ROE (Return on Equity):16.25%
ROA (Return on Assets):7.03%
P/E (trailing):21.94
P/E (forward):15.58
Price / Book:3.65
PEG Ratio:1.53
52-Week Change:+20.91%
S&P 500 change, 52 weeks:+11.37%

Historical Evolution (Last 4 Years)

Income Statement

Balance Sheet

Cash Flow

EPS and Earnings Per Share

Key EPS Metrics

EPS Trailing (TTM):$0.88

Diluted EPS for the last 12 months: the four quarters ended Sep 27, 2026, from the accounts filed with the SEC on Oct 30, 2026. The P/E is the price divided by that EPS.

EPS Forward (Est.):$1.24
P/E (forward):15.58
PEG Ratio:1.53

Growth and Margins

Earnings Growth YoY:-
Quarterly Earnings Growth YoY:-
Rev Growth YoY:-
Net Margin:-
Gross Margin:-
EBITDA Margin:-

Per Share

Revenue Per Share:$8.10
Cash Per Share:-
Book Value:$5.29

Cash Flows (TTM)

Free Cash Flow:2.77B
Operating Cash Flow:2.73B
EBITDA:3.50B
Total Revenue (TTM):15.53B
Net Income (TTM):1.69B
Fiscal Year (Last):-

EPS Surprise History - Last 4 Quarters

Actual vs. Analyst Estimates · Green = beat expectations · Red = missed

Quarter Period Actual EPS Estimated EPS Difference Surprise % Currency

Ownership Structure

Ownership Distribution

% Insiders:-
% Institutional:-
% Inst. (of Float):-
No. of Institutions:-
Visual distribution
InsidersInstitutionalFree Float

Shares & Short Interest

Shares Outstanding:1,921,768,446
Float (free shares):1,918,981,882
Short interest (shares):55,696,920
Short % of float:-
Short Ratio (days to cover):2.56
Short interest, prior month:-
Short Interest Date:-

Governance Score (1=Best, 10=Worst)

Overall risk:-
Audit Risk:-
Board risk:-
Compensation Risk:-
Shareholder rights risk:-

Top Institutional Holders

Position Change: ▲ Increased · ▼ Reduced · = Unchanged

Organization Report Date % Shares No. Shares Value (USD) Change %

Top Mutual Funds

Position Change: ▲ Increased ▼ Decreased = Unchanged

Fund Report Date % Shares No. Shares Value (USD) Change %

Recent Insider Trades

Executive / Insider Title Date Action Shares

Options Chain

CALLS

StrikeLastBidAskVol.O.I.IV

PUTS

StrikeLastBidAskVol.O.I.IV

Kenvue Inc. (KVUE) SEC filings: 10-K, 10-Q and 8-K

Direct links to financial reports filed with the SEC.

Type Date Official link
25-NSE2026-11-02View filing ↗
8-K2026-10-30View filing ↗
8-K2026-10-13View filing ↗
10-Q2026-08-06View filing ↗
SD2026-05-28View filing ↗
8-K2026-05-22View filing ↗
10-Q2026-05-07View filing ↗
8-K2026-04-15View filing ↗
DEFA14A2026-04-08View filing ↗
10-K2026-02-20View filing ↗

Company and Executive Profile

Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.

General Information

Headquarters:United States
City:Summit
Employees:21,780
Industry:Household & Personal Products
Website:-

Key Executives

NameTitleAgeTotal pay
Mr. Kirk L. PerryCEO & Director582.94M
Mr. Michael P. WondraschChief Technology & Data Officer561.02M
Mr. Matthew OrlandoGeneral Counsel481.25M
Mr. Carlton LawsonGroup President of Europe, Middle East & Africa561.41M
Ms. Heather R. HowlettInterim CFO & Chief Accounting Officer47-
Ms. Meredith StevensChief Operations Officer621.83M
Dr. Caroline Tillett Ph.D.Chief Scientific Officer53-
Mr. Jonathan HalvorsonChief Digital & Marketing Officer42-

You have seen the engine room

A free account saves your simulator portfolios, your personal portfolio and your Academy progress, synced across devices. And, if you switch it on, the email alert the same day an insider buys stock in their own company.

No card. No spam.

Kenvue Inc. (KVUE): Quantitative Analysis

Kenvue Inc. (KVUE) — Consumer Defensive — Household & Personal Products. KVUE is in the S&P 500 today. Model factor scores and market data, recalculated every trading day.

So far in 2026, KVUE has returned +16.8% against +11.6% for the S&P 500 (SPY): total return, dividends included on both sides, from Dec 31, 2025 to Oct 30, 2026.

KVUE is not in today's ranking, so no scores are shown. Only S&P 500 companies with enough fundamentals to score all four factors are included.

Market data

MetricValue
Price$19.31
Market Cap37.11B
P/E21.94
Revenue (last 12 months)15.53B
Price / book3.65
Book value per share$5.29
52-week range$15.88 – $20.13
Dividend yield4.35%
Beta0.40
Average volume22,508,816
Shares outstanding1.92B
Short interest (% of float)3.36% (as of Oct 15, 2026)

When does KVUE report earnings? 9 of its last 10, before the open →

What are KVUE insiders doing? 68 transactions filed with the SEC, of them 2 buys and 2 sells, the last one on Nov 2, 2026 →

KVUE latest SEC filings

Filing dates on EDGAR, the SEC's public registry. All KVUE filings on EDGAR.

Guides: How to read a Quant500 company page · What the S&P 500 is · P/E ratio explained · 10-K, 10-Q and 8-K · all guides

Frequently asked questions about Kenvue (KVUE)

When does Kenvue report earnings?

Kenvue has no announced date in the Nasdaq public calendar checked (Nov 3, 2026 to Dec 7, 2026). Of its last 12 earnings announcements: 1 after the close and 9 before the open (and 2 with no time on the filing) (SEC filings through Oct 30, 2026). KVUE earnings dates and times, quarter by quarter →

What is Kenvue's P/E ratio?

Kenvue's P/E (price over earnings per share for the last twelve months) is 21.9 at the Oct 30, 2026 close. That EPS is the 12-month diluted figure from the SEC, the four quarters ended Sep 27, 2026. The median of the 30 Consumer Defensive companies with a P/E is 21.2, and the S&P 500's, 23.5: Kenvue is above its sector median. Consumer Defensive stocks, company by company →

Have Kenvue insiders bought or sold shares?

The latest open-market purchase of Kenvue shares filed with the SEC (Form 4) was on Dec 12, 2025, by a director, for $55.6M. The latest sale was on Jun 10, 2026, by an officer, for $67k. In total, from August 2025 through Nov 3, 2026: 2 purchases and 2 sales by directors, officers and large shareholders. All KVUE insider trades →

Does Kenvue pay a dividend?

Yes. Its dividend yield is 4.35% at the Oct 30, 2026 close (annual dividend of $0.84 per share). The latest recorded ex-dividend date is Sep 21, 2026.

What sector is Kenvue in, and which index?

Kenvue is classified in the Consumer Defensive sector (industry: Household & Personal Products), per the data provider's classification (similar to GICS, not identical). It is in the S&P 500 today. It is one of the 33 S&P 500 companies in that sector. Consumer Defensive stocks →

What is behind these numbers

The concepts on this page, explained from scratch in the Academy. Free, no account.

The whole Academy, course by course →

Data as of Nov 3, 2026. Source: point-in-time SEC fundamentals and closing prices. Method and formulas are on the home page.

The model portfolio, weekly in your inbox

Every Saturday, its week in one minute: how it went, the best and the worst, and which insiders bought with their own money. Plus, the day the model is rebuilt, which stocks come in and which go out. A simulation, not advice. At most one email a week, no ads, no account; one-click unsubscribe. Made by one person: Pol Gracia.

A model portfolio with simulated results, not a personalized recommendation. Your email is used for this only: privacy.

S&P 500 market gravity